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Abstract
Background Recent cohort studies have suggested an
increased risk of breast cancer with long duration of smoking,
and with smoking initiation before first birth. Cigarette smoking
may have both carcinogenic effects and antiestrogenic effects
on the breast tissue. We decided to examine the relationship
between different measures of smoking exposure and
mammographic density.
Methods Lifetime smoking history was collected through
interview and questionnaires among 907 postmenopausal
participants in the Tromsø Mammography and Breast Cancer
study. The mammograms were obtained from the governmental
Norwegian Breast Cancer Screening Program. Mammograms
were classified according to the percentage and absolute
mammographic densities using a previously validated computer-
assisted method.
Results Sixty-five percent of the women reported having ever
smoked cigarettes, while 34% were current smokers. After
adjustment for age, age at first birth, parity, age at menopause,
postmenopausal hormone therapy use, and body mass index,
smoking was inversely associated with both measures of
mammographic density (both trends P < 0.01). Both current
smokers and former smokers had significantly lower adjusted
mean percentage mammographic density compared with never
smokers (P = 0.003 and P = 0.006, respectively). An inverse
dose–response relationship with mammographic density was
found between both the number of cigarettes and the number of
pack-years smoked among current smokers. Current smokers
who smoked 11 cigarettes or more daily had a 3.7% absolute
(36% relative difference) lower percentage mammographic
density compared with current smokers who smoked seven
cigarettes or less daily (P = 0.008). When former smokers were
stratified according to time since smoking cessation, we found
that women who had stopped smoking less than 24 years ago
had a significantly lower mean percentage mammographic
density compared with never smokers (P < 0.001).
Conclusion We found modest inverse dose–response
associations between numbers of cigarettes and of pack-years
smoked and both measures of mammographic density among
current smokers. Former smokers who had stopped smoking
less than 24 years ago also had a statistically significantly lower
mean percentage mammographic density when compared with
never smokers. These findings are consistent with an
antiestrogenic effect of cigarette smoking on the breast tissue.
Introduction
Constituents in tobacco smoke may have carcinogenic effects
on the breast tissue [1-3]. Tobacco smoking, however, may
also have antiestrogenic effects that can reduce breast cancer
risk [4,5]. These opposing effects may explain the overall
inconsistent results from epidemiologic studies on the associ-
ation between smoking and breast cancer risk [2,6-9].
Although most case–control studies do not find any positive
associations [2,10], however, several recent cohort studies
have indicated an increased breast cancer risk among women
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who are long-term smokers [11-14], and also among those
who start to smoke before their first birth [12-17].
Mammographic density is one of the strongest independent
risk factors for breast cancer [18,19], and possibly an interme-
diate marker for breast cancer [20]. Women with high mam-
mographic density have a fourfold to sixfold increase in breast
cancer risk compared with those with low mammographic
density [18,19].
The results so far published on the association between smok-
ing and mammographic density have also been conflicting
[21-27]. One explanation for this may be that most studies
have used crude (for example, ever/never) measures of smok-
ing exposure.
The objective of the present cross-sectional study was to
examine the relationship between cigarette smoking and mam-
mographic density among postmenopausal women with a high
smoking prevalence, according to different measures of smok-
ing exposure.
Materials and methods
Study population
The Tromsø Mammography and Breast Cancer Study was
conducted among postmenopausal women, aged 55–71
years, residing in the municipality of Tromsø, Norway, and
attending the population-based Norwegian Breast Cancer
Screening Program at the University Hospital of North Norway
[28]. Women were recruited in spring 2001 and in spring
2002. After the women had undergone their screening mam-
mograms, they were interviewed by a trained research nurse
about reproductive and menstrual factors, previous history of
cancer, current smoking status, and use of postmenopausal
hormone therapy (HT) or other medications. The participants
had their height measured to the nearest centimeter and their
weight measured to the nearest half kilogram. Women had
blood samples drawn, and each participant was subsequently
given a questionnaire to be completed at home, eliciting infor-
mation on demographics, additional menstrual and reproduc-
tive factors, lifetime smoking history, as well as lifestyle and
dietary factors. All women signed an informed consent. The
National Data Inspection Board and the Regional Committee
for Medical Research Ethics approved the study. Altogether,
1,041 women were included in this cross-sectional study. This
accounted for 70% of the women attending the Norwegian
Breast Cancer Screening Program during the recruitment
period.
We excluded 22 women because of a previously diagnosed (n
= 16) or a newly diagnosed (n = 6) breast cancer, and one
woman because of an ongoing chemotherapy treatment.
Among the remaining 1,018 women, we were unable to
retrieve mammograms on 11 women. We therefore obtained
mammographic density readings on 1,007 women. More
details are described elsewhere [28]. We further excluded
three women because they were equivocal for menopausal
status and excluded 97 women because of a missing smoking
history, leaving 907 women for the analyses.
Mammographic classifications
The women's left cranio-caudal mammogram was digitized
using a Cobrascan CX-812 scanner (Radiographic Digital
Imaging, Torrance, CA, USA) at a resolution of 150 pixels per
inch. Percentage and absolute mammographic densities were
determined by an experienced reader (GU) using the Univer-
sity of Southern California Madena computer-based threshold
method, which has been described in detail and validated
elsewhere [29]. Briefly, the method works as follows. The dig-
itized mammographic image is viewed on a computer screen.
A reader defines the total breast area using a special outlining
tool. Next, the region of interest – excluding the pectoralis
muscle, prominent veins, and fibrous strands – is defined. The
computer software program assigns a pixel value of 0 to the
darkest (black) shade in the image and a value of 255 to the
lightest (white) shade, with shades of grey assigned to inter-
mediate values. The reader then uses a tinting tool to apply a
yellow tint to dense pixels with grey levels at or above some
threshold X and a pixel value ≤ 255. The reader searches for
the best threshold where all pixels ≥ X within the region of
interest are considered to represent mammographic densities.
The software estimates the total number of pixels and the
number of tinted pixels within the region of interest. The abso-
lute density represents the count of the tinted pixels within the
region of interest. The percentage density, or the fraction (%)
of the breast with densities, is the ratio of the absolute density
to the total breast area multiplied by 100. The absolute density
(measured in centimeters squared) was calculated as the
number of tinted pixels within the region of interest divided by
the number of pixels per centimeter squared.
The reader of the mammograms was blinded to characteristics
of the study participants. We have previously shown a high
intra-rater agreement for the reader in our study (Pearson cor-
relation coefficient = 0.86) [28].
Smoking assessments
The women were interviewed about their current smoking sta-
tus. The self-administered questionnaire elicited additional
information on the participant's lifetime smoking history.
Women reporting never having smoked or never having been
exposed to passive smoking were categorized as 'never active
smokers'. We further categorized women who had never
actively smoked but had been exposed to passive smoking at
home or at the workplace as 'passive smokers'. Never active
smokers and passive smokers were also grouped together as
'never smokers'. This group serves as the reference group in
all analyses, if not specified otherwise. Current smokers and
former smokers were grouped together as 'ever-smokers'.
Pack-years were calculated as the number of cigarettesAvailable online http://breast-cancer-research.com/content/9/5/R73
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smoked daily divided by 20 and multiplied by the number of
years smoked.
We categorized former smokers according to the time since
smoking cessation (tertiles). We categorized current smokers
according to their age at smoking initiation (tertiles), to the
average number of cigarettes smoked per day (tertiles), to the
number of years smoked (≤ 25 years, 26–40 years, 41+
years), to the number of pack-years smoked (tertiles), and
parous women according to smoking initiation before or after
first birth.
Statistical analyses
Mammographic density was not normally distributed. Both the
percentage and absolute mammographic densities were log-
transformed to obtain approximate normal distributions. We
used analysis of variance for an unbalanced design to study
the associations between cigarette smoking and mammo-
graphic densities (Proc GLM; SAS Institute Inc., Cary, NC,
USA).
Each of the following factors was evaluated as a potential con-
founder of the association between smoking and mammo-
graphic density: age at screening (continuous), age at
menarche (continuous), age at menopause (continuous),
number of children (continuous), age at first birth (continuous),
years of education (continuous), family history of breast cancer
in first-degree relatives (yes, no), alcohol intake (g/day, contin-
uous), HT use (never used, past use, current use), and body
mass index (BMI) (weight in kilogram divided by height in
meters squared; continuous).
The variables of age at screening, number of children, HT use,
and BMI have previously been found associated with mammo-
graphic density in this study population [28,30], and were
always adjusted for as confounders in the multivariate analy-
ses. We further identified those of the above listed variables
that were associated with cigarette smoking in univariate anal-
yses, and that also were significantly associated with mammo-
graphic density in the multivariate analyses. This procedure left
the following factors in the final model: age at screening, age
at first birth, number of children, age at menopause, HT use
and BMI. Women with missing values were excluded from the
analyses (<10%).
Reported trend-test P values correspond to analyses where
the categories of cigarette smoking were treated as ordered
variables. We tested for possible effect modification by analyz-
ing the association between smoking and mammographic
density stratified by the confounders, and by adding multiplica-
tive interaction terms to the analysis of variance procedure.
The crude and adjusted mean mammographic density results
were back-transformed, and are presented with 95% confi-
dence intervals. Results were considered statistically signifi-
cant if the two-sided P value was < 0.05. We conducted all
statistical analyses using SAS® 9.1 for Windows (SAS Insti-
tute Inc.).
Results
Altogether, 65% of the women were ever smokers. Among the
310 (34%) women who reported current smoking, 82%
smoked daily. Altogether, 318 women reported to have never
been smokers, among whom 73% reported to have been
exposed to passive smoking at home or at the workplace.
Table 1 presents the distribution of selected characteristics
according to smoking status. Current smokers were younger
at screening, were younger at time of first birth, had less formal
education, reached menopause at an earlier age, were leaner,
and were more likely to have ever used oral contraceptives,
when compared with never smokers (all P ≤ 0.02).
Former smokers also differed from never smokers, their data
values being between current smokers and never smokers,
with regard to age at first birth and ever oral contraceptive use
(both P ≤ 0.007). Former smokers had a significantly higher
BMI when compared with never smokers (P = 0.04). Passive
smokers were more likely to have ever used HT (P < 0.05), but
were otherwise similar to never smokers in the other measured
characteristics (results not shown).
Table 2 presents the median, the crude mean and the adjusted
mean mammographic densities across smoking status. Both
current smokers and former smokers had lower crude mean
mammographic density compared with never smokers,
according to both the percentage and the absolute mammo-
graphic densities. When the associations were adjusted for
age at screening, for age at first birth, for number of children,
for age at menopause, for HT use and for BMI, both current
smokers and former smokers had a significantly lower
adjusted mean percentage mammographic density compared
with never smokers (P = 0.003 and P = 0.006, respectively).
The magnitude of the difference in the mean percentage mam-
mographic density between current smokers and never smok-
ers was 2.2% absolute (23% relative) difference. A similar
association was found between smoking status and absolute
mammographic density (Table 2). These associations did not
change materially when we excluded passive smokers from
never smokers (results not shown), or when we excluded
occasional smokers from current smokers (results not shown).
Current smokers on average smoked 10 cigarettes per day.
The majority of current smokers had initiated smoking by the
age of 20, and had been smoking for 39 years or more. Among
those reporting to be former smokers, 71% had stopped
smoking 10 years or more ago. Table 3 presents the associa-
tion between different measures of smoking exposure and the
percentage mammographic density among current smokers,
and according to time since smoking cessation among formerBreast Cancer Research    Vol 9 No 5    Bremnes et al.
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smokers. We found an inverse dose–response relationship
between the number of cigarettes smoked daily and the per-
centage mammographic density among current smokers (P =
0.008), and this remained when the analysis was further
restricted to current smokers who had smoked for 25 years or
more (P = 0.01). Current smokers who smoked 11 cigarettes
or more daily had a 3.7% absolute (36% relative difference)
lower mean percentage mammographic density compared
with current smokers who smoked seven cigarettes or less
daily (P  = 0.008). Furthermore, an inverse dose–response
relationship was found between the number of pack-years and
the percentage mammographic density among current smok-
ers (P = 0.09). When former smokers were stratified accord-
ing to time since smoking cessation, we found that women
who had stopped smoking less than 24 years ago had a sig-
nificantly lower mean percentage mammographic density
compared with never smokers (P < 0.001). These associa-
tions were similar when absolute mammographic density was
used as the outcome variable (results not shown).
Table 1
Characteristics of the study population (n = 907) by smoking status
Characteristic Smoking status P 
valuea
Current smokers (n = 310) Former smokers (n = 279) Never smokers (n = 318)
Age at screening (years) 60.7 (4.4) 61.6 (4.5) 61.9 (4.6) <0.001
Age at menarche (years) 13.3 (1.4) 13.3 (1.4) 13.3 (1.4) 0.47
Age at first birthb (years) 22.3 (3.6) 22.7 (3.3) 23.5 (3.9) <0.001
Number of childrenb 2.9 (1.2) 2.8 (1.1) 2.9 (1.4) 0.82
Education (years) 9.4 (3.2) 9.7 (3.4) 10.2 (3.6) 0.02
Age at menopause (years) 47.5 (5.5) 48.8 (4.8) 49.1 (4.8) <0.001
Body mass index (kg/m2) 26.1 (4.4) 28.4 (5.1) 27.6 (4.7) <0.001
Alcohol consumptionc (g/day) 3.8 (3.8) 4.0 (3.9) 3.4 (4.0) 0.36
Ever oral contraceptive use (%) 54.8 49.5 37.4 <0.001
Parous (%) 93.6 93.6 90.3 0.13
Ever postmenopausal hormone therapy use (%) 43.2 45.2 41.8 0.72
Breast cancer in first-degree relative (%) 6.8 9.3 9.8 0.18
Data presented as the mean (standard deviation) or as the frequency. aCurrent smokers versus never smokers. bAmong parous women 
only.cAmong alcohol drinkers only.
Table 2
Median, crude mean and adjusted mean percentage and absolute mammographic density by smoking status
Smoking status n Percentage mammographic density (%) Absolute mammographic density (cm2)
Median (range) Crude mean 
(95% confidence 
interval)
Adjusted mean 
(95% confidence 
interval)
Median (range) Crude mean 
(95% confidence 
interval)
Adjusted mean 
(95% confidence 
interval)
Current 
smokers
310 9.4 (0–59.4) 8.0 (7.0–9.1) 7.3 (6.5–8.3) 13.7 (0–110.1) 10.7 (9.4–12.2) 10.4 (9.0–12.0)
Former 
smokers
279 7.7 (0–51.1) 6.7 (5.8–7.7) 7.5 (6.6–8.5) 11.9 (0–155.2) 9.7 (8.4–11.4) 10.6 (9.2–12.2)
Never smokers 318 11.9 (0–69.2) 9.7 (8.6–11.0) 9.5 (8.4–10.7) 17.1 (0–152.3) 14.0 (12.3–15.9) 13.7 (11.9–15.7)
P valuea 0.03 0.003 0.004 0.005
P valueb <0.001 0.006 <0.001 0.01
Analyses are adjusted for age at screening, age at first birth, number of children, age at menopause, postmenopausal hormone therapy use, and 
body mass index. Reported means are back-transformed from log-transformed estimated means. aCurrent smokers versus never smokers. bFormer 
smokers versus never smokers.Available online http://breast-cancer-research.com/content/9/5/R73
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Discussion
This population-based cross-sectional study found an inverse
association between smoking and percentage mammographic
density among postmenopausal women, after adjustment for
potential confounders. We also observed an inverse dose–
response relationship among current smokers between both
the numbers of cigarettes and pack-years smoked and the per-
centage mammographic density. Women who had stopped
smoking less than 24 years ago had a significantly lower mean
percentage mammographic density compared with never
smokers These associations were similar when absolute mam-
mographic density was used as the outcome variable.
The strengths of our study are the large sample size and that
it was a part of a population-based screening program with a
high attendance rate [31]. The reader of the mammograms
Table 3
Adjusted mean percentage mammographic density according to smoking exposure among current smokers, and according to time 
since smoking cessation among former smokers
Smoking exposure n Adjusted mean percent mammographic density (95% confidence interval)
Current smokers Former smokers
Number of cigarettes smoked per day
≤ 7 cigarettes 87 10.3 (8.2–12.8)
8–10 cigarettes 79 9.0 (7.0–11.5)
≥ 11 cigarettes 77 6.6 (5.2–84)
P trend 0.008
Number of years smoked
≤ 25 years 56 8.9 (6.8–11.8)
26–40 years 92 8.8 (6.9–11.3)
≥ 41 years 95 8.1 (6.5–10.1)
P trend 0.57
Number of pack-years smoked
≤ 11 pack-years 82 10.0 (7.9–12.6)
12–20 pack-years 85 8.5 (6.7–10.8)
≥ 21 pack-years 75 7.5 (5.9–9.6)
P trend 0.09
Age at smoking initiation
≥ 21 years 94 8.9 (7.1–11.1)
18–20 years 114 8.4 (6.8–10.3)
13–17 years 78 7.3 (5.8–9.3)
P trend 0.26
Smoking initiation before first birtha
No 79 9.2 (7.2–11.8)
Yes 186 7.8 (6.7–9.1)
P value 0.24
Time since smoking cessation
≥ 24 years 89 8.5 (6.7–10.7)
12–23 years 89 5.2 (4.0–6.7)
≤ 11 years 88 6.5 (5.1–8.2)
P trend 0.12
Analyses are adjusted for age at screening, age at first birth, number of children, age at menopause, postmenopausal hormone therapy use, and 
body mass index. Reported means are back-transformed from log-transformed estimated means. aAmong parous women only.Breast Cancer Research    Vol 9 No 5    Bremnes et al.
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was experienced and blinded to the characteristics of the
women. We have previously shown a high intra-rater agree-
ment for the reader in our study [28]. Further, we have
assessed both relative and absolute measures of mammo-
graphic density as outcome variables, since they may be influ-
enced differently by residual confounding by adiposity [32],
and we found similar associations between smoking and mam-
mographic density when we performed the analyses using the
absolute mammographic density as the outcome variable.
Another strength is that we have a large proportion of current
smokers (34%) among the women in our study compared with
previous studies among postmenopausal women, which all
had less than 14% current smokers [21-24].
One limitation of our study is the possible misclassification of
smoking exposure. Any misclassification of smoking would
presumably be nondifferential with respect to mammographic
density, and would therefore be expected to bias the results
toward the null association. Another limitation is that the
median mammographic density in our study is low and that
mammographic density has a narrow range. In another study
with a different reader, however, women from our study had
significantly lower percentage mammographic density com-
pared with Caucasians from Hawaii and Arizona [33].
In a study from the United States, Modugno and colleagues
also found that current smokers had a significantly lower per-
centage mammographic density compared with noncurrent
smokers. Their study, comprising 239 women aged 70 years
or older, only had information about current smoking habits
and therefore could not analyze the association in more detail
[21].
Three other studies found no association between smoking
and mammographic density among postmenopausal women
[22-24]. In a British study with 406 women from Norfolk, Sala
and colleagues found no significant association between
smoking and high-risk Wolfe's parenchymal patterns among
the 313 postmenopausal women in their study, even though
current smokers had a significantly reduced odds ratio of hav-
ing high-risk Wolfe's parenchymal patterns compared with
never smokers when the analyses also included premenopau-
sal women [22]. In an American study including 191 Hispanic
women, Gapstur and colleagues found no association
between smoking and mammographic density [23]. In another
American study, Vachon and colleagues did not find any asso-
ciation between smoking duration and intensity and the per-
cent mammographic density among 1,554 postmenopausal
women, but an inverse association was found among the 346
premenopausal women in their study [24].
Mammographic density is an independent risk factor for breast
cancer, and lower mammographic density could suggest
lower risk for breast cancer [18,19]. One of the suggested
mechanisms for how smoking might increases the risk of
breast cancer is carcinogenic effects of constituents in
tobacco smoke on the breast tissue [1-3]. It is possible that
this suggested mechanism does not affect mammographic
density, and thus would not influence mammographic density
as measured in our study.
Conversely, the other suggested effect of smoking is believed
to be an antiestrogenic effect [4,5,34]. Smoking has been
shown to enhance the metabolism of estradiol to metabolites
believed to have minimal peripheral estrogen activity, to
increase estrogen binding by sex-hormone binding globulin
and, because smokers tend to be leaner than nonsmokers, to
lower the amount of estrogens derived from adipose tissue
[4,5]. It has been shown that mammographic density may be
intentionally manipulated by hormonal treatments such as
tamoxifen or a gonadotropin-releasing hormone agonist
[35,36]. A change in serum estrogen levels has also been
shown to influence mammographic density [37]. The findings
in the present study are consistent with an antiestrogenic
effect of cigarette smoking on breast tissue, reflected in lower
mammographic density among smokers.
We do not, however, believe our finding that current and
former smokers have lower mean mammographic density
when compared with never smokers will be reflected in a lower
risk of breast cancer among smokers. The magnitudes of the
difference in the mean percentage mammographic density
between current smokers and never smokers were modest
and may be due to residual confounding. We have previously
shown that, in this study population, women using a continu-
ous estrogen and progestin combination HT for 5 years or
longer had a significantly higher percentage mammographic
density compared with never HT users. The magnitude of that
difference was substantially higher (7% absolute difference,
100% relative difference) than what we observed in the cur-
rent study [30], suggesting that the effect of cigarette smoking
may not be clinically relevant. Our finding that former smokers
who had stopped smoking less than 24 years ago had statis-
tically significantly lower mammographic density when
compared with never smokers may partly be due to misclassi-
fication of current smokers as former smokers, as well as due
to residual confounding. Boyd and colleagues, however, have
proposed that the cumulative exposure to dense mammo-
graphic breast tissue could be represented by the area under
the curve of the Pike and colleagues model for breast tissue
ageing [38]. If there is an antiestrogenic effect of smoking,
therefore, former smoking may have increased the age-related
decrease in mammographic density.
Conclusion
We found inverse associations between cigarette smoking
and both the percentage and absolute mammographic densi-
ties among postmenopausal women in our cross-sectional
study. We also observed a modest inverse dose–response
association among current smokers between the amountAvailable online http://breast-cancer-research.com/content/9/5/R73
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smoked and the mammographic density. Also, former smokers
who had stopped smoking less than 24 years ago had a sta-
tistically significantly lower mean percentage mammographic
density when compared with never smokers. Our results are
consistent with an antiestrogenic effect of smoking on the
breast tissue, as measured by mammographic density.
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